99mTc labeled D(LPR): A novel retro-inverso peptide for VEGF receptor-1 targeted tumor imaging

Harisinghani, 2003, Noninvasive detection of clinically occult lymph-node metastases in prostate cancer, N Engl J Med, 348, 2491, 10.1056/NEJMoa022749 Reubi, 2003, Peptide receptors as molecular targets for cancer diagnosis and therapy, Endocr Rev, 24, 389, 10.1210/er.2002-0007 Heppeler, 2000, Receptor targeting for tumor localisation and therapy with radiopeptides, Curr Med Chem, 7, 971, 10.2174/0929867003374516 Ghosh, 2008, High levels of vascular endothelial growth factor and its receptors (VEGFR-1, VEGFR-2, neuropilin-1) are associated with worse outcome in breast cancer, Hum Pathol, 39, 1835, 10.1016/j.humpath.2008.06.004 Relf, 1997, Cancer Res, 57, 963 Roskoski, 2008, VEGF receptor protein–tyrosine kinases: structure and regulation, Biochem Biophys Res Commun, 375, 287, 10.1016/j.bbrc.2008.07.121 Fan, 2005, Expression and function of vascular endothelial growth factor receptor-1 on human colorectal cancer cells, Oncogene, 24, 2647, 10.1038/sj.onc.1208246 Wu, 2006, The vascular endothelial growth factor receptor (VEGFR-1) supports growth and survival of human breast carcinoma, Int J Cancer, 119, 1519, 10.1002/ijc.21865 Carrillo De Santa Pau, 2009, Prognostic significance of the expression of vascular endothelial growth factors A, B, C, and D and their receptors R1, R2, and R3 in patients with nonsmall cell lung cancer, Cancer, 115, 1701, 10.1002/cncr.24193 Wey, 2005, Vascular endothelial growth factor receptor-1 promotes migration and invasion in pancreatic carcinoma cell lines, Cancer, 104, 427, 10.1002/cncr.21145 Lesslie, 2006, Vascular endothelial growth factor receptor-1 mediates migration of human colorectal carcinoma cells by activation of Src family kinases, Br J Cancer, 94, 1710, 10.1038/sj.bjc.6603143 Backer, 2012, Imaging key biomarkers of tumor angiogenesis, Theranostics, 2, 502, 10.7150/thno.3623 Backer, 2007, Molecular imaging of VEGF receptors in angiogenic vasculature with single-chain VEGF-based probes, Nat Med, 13, 504, 10.1038/nm1522 Cai, 2006, PET of vascular endothelial growth factor receptor expression, J Nucl Med, 47, 2048 Giordano, 2010, From combinatorial peptide selection to drug prototype (I): targeting the vascular endothelial growth factor receptor pathway, Proc Natl Acad Sci, 107, 5112, 10.1073/pnas.0915141107 Pallai, 1983, Approaches to the synthesis of retro-inverso peptides, Chem Biol Drug Des, 21, 84 Chorev, 2005, The partial retro–inverso modification: a road traveled together, Pept Sci, 80, 67, 10.1002/bip.20219 Emrarian, 2018, New neurotensin analogue radiolabeled by 99m-technetium as a potential agent for tumor identification, Chem Biol Drug Des, 91, 304, 10.1111/cbdd.13082 Carmeliet, 2001, Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions, Nat Med, 7, 575, 10.1038/87904 Kaplan, 2005, VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche, Nature, 438, 820, 10.1038/nature04186 Pan, 2007, Blocking neuropilin-1 function has an additive effect with anti-VEGF to inhibit tumor growth, Cancer Cell, 11, 53, 10.1016/j.ccr.2006.10.018 Cai, 2008, Multimodality molecular imaging of tumor angiogenesis, J Nucl Med, 49, 113S, 10.2967/jnumed.107.045922 Yoshimoto, 2006, Radioiodinated VEGF to image tumor angiogenesis in a LS180 tumor xenograft model, Nucl Med Biol, 33, 963, 10.1016/j.nucmedbio.2006.08.006 Chen, 2009, Quantitative PET imaging of VEGF receptor expression, Mol Imaging Biol, 11, 15, 10.1007/s11307-008-0172-1 Wang, 2007, A new PET tracer specific for vascular endothelial growth factor receptor 2, Eur J Nucl Med Mol Imaging, 34, 2001, 10.1007/s00259-007-0524-0 Niccoli Asabella, 2017, Multimodality imaging in tumor angiogenesis: present status and perspectives, Int J Mol Sci, 18, 1864, 10.3390/ijms18091864 Giordano, 2001, Biopanning and rapid analysis of selective interactive ligands, Nat Med, 7, 1249, 10.1038/nm1101-1249 Giordano, 2005, Structural basis for the interaction of a vascular endothelial growth factor mimic peptide motif and its corresponding receptors, Chem Biol, 12, 1075, 10.1016/j.chembiol.2005.07.008 Fischer, 2003, The design, synthesis and application of stereochemical and directional peptide isomers: a critical review, Curr Protein Pept Sci, 4, 339, 10.2174/1389203033487054 Decristoforo, 1999, 99m-technetium-labelled peptide-HYNIC conjugates: effects of lipophilicity and stability on biodistribution, Nucl Med Biol, 26, 389, 10.1016/S0969-8051(98)00118-8 Imoukhuede, 2014, Quantitative fluorescent profiling of VEGFRs reveals tumor cell and endothelial cell heterogeneity in breast cancer xenografts, Cancer Med, 3, 225, 10.1002/cam4.188 Morris, 2016, Development & automation of a novel [18 F] F prosthetic group, 2-[18 F]-fluoro-3-pyridinecarboxaldehyde, and its application to an amino (oxy)-functionalised Aβ peptide, Appl Radiat Isot, 116, 120, 10.1016/j.apradiso.2016.07.023 Li, 2010, Limitations of peptide retro-inverso isomerization in molecular mimicry, J Biol Chem, 285, 19572, 10.1074/jbc.M110.116814 Bogdanowich-Knipp, 1999, Solution stability of linear vs. cyclic RGD peptides, Chem Biol Drug Des, 53, 530 Karimi, 2017, Radiochemical evaluation and In vitro assessment of the targeting ability of a novel 99mTc-HYNIC-RGD for U87MG human brain cancer cells, Curr Radiopharm, 10, 139, 10.2174/1874471010666170706164016